Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Nanoscale Velcro Proteins Discovered to Be Used for Molecule Transport

By BiotechDaily International staff writers
Posted on 01 Jul 2014
Image: An import protein coated molecule moving on the “dirty velcro” (Photo courtesy of Biozentrum, University of Basel).
Image: An import protein coated molecule moving on the “dirty velcro” (Photo courtesy of Biozentrum, University of Basel).
Biologic membranes perform similar to a guarded border. They separate the cell from their environment and at the same time control the coming and going of molecules. The nuclear membrane can be crossed via many tiny pores. Scientists have now discovered that proteins found within the nuclear pore function similar to a “Velcro” snap. They reported how these proteins can be used for controlled and selective transport of particles.

Scientists at the Biozentrum (Basel, Switzerland) and the Swiss Nanoscience Institute at the University of Basel (Switzerland), together with an international team of researchers, have published online June 15, 2014, in the journal Nature Nanotechnology, they reported how these proteins can be used for controlled and selective transport of particles.

Cells are always moving around. Many proteins, for example, need to travel from their production site in the cytoplasm to the nucleus, where they are used to read genetic information. Pores in the nuclear membrane enable their transport into and out of the cell nucleus. Prof. Roderick Lim, from the Biozentrum and the Swiss Nanoscience Institute at the University of Basel, studies the biophysic basics of this transport. To better determine this process, he has created a synthetic model of the nuclear pore complex, working with scientists from Lausanne (Switzerland) and Cambridge (UK), which has led to the discovery that its proteins function similar to a nanoscale Velcro, which can be used to transport tiniest particles.

Nuclear pores are protein complexes within the nuclear membrane that enables molecular exchange between the cytoplasm and nucleus. The major force is diffusion. Nuclear pores are lined with Velcro-like proteins. Only molecules specifically tagged with import proteins can bind to these proteins and therefore pass the pore. But for all nonbinding molecules, the nuclear pore acts as a barrier. The researchers hypothesized that transport depends on the strength of binding to the Velcro-like proteins. The binding should be just strong enough that molecules to be transported can bind but at the same time not too tight so that they can still diffuse through the pore.

In a synthetic system recreating the nuclear pore, the researchers assessed their therapy. They coated particles with import proteins and studied their behavior on the molecular Velcro. Surprisingly, the researchers discovered similarities in behavior to the Velcro strip’s features. On “clean Velcro,” the particles instantly adhere. However, when the Velcro is filled or “dirtied” import proteins, it is less sticky and the particles start to slide over its surface just by diffusion. “Understanding how the transport process functions in the nuclear pore complex was decisive for our discovery,” said Prof. Lim. “With the nanoscale Velcro we should be able to define the path to be taken as well as speed up the transport of selected particles without requiring external energy.”

Prof. Lim’s study of biomolecular transport mechanism form the foundation for the discovery of this amazing phenomenon that particles can be transported selectively with a molecular Velcro. His principle could find very practical applications, for instance as nanoscale conveyor belts, escalators, or tracks, explained Prof. Lim.

This could also potentially be applied to advanced miniaturize lab-on-chip technology, miniscule labs on chips, where this newly discovered approach to transporting would make modern complicated pump and valve systems a thing of the past, according to the scientists.

Related Links:

Biozentrum at the University of Basel 
Swiss Nanoscience Institute at the University of Basel



Channels

Genomics/Proteomics

view channel
Image: The bone marrow of mice with normal ether lipid production (top) contains more white blood cells than are found in the bone marrow of mice with ether lipid deficiency (bottom) (Photo courtesy of Washington University School of Medicine).

Inactivating Fatty Acid Synthase Reduces Inflammation by Interfering with Neutrophil Membrane Function

The enzyme fatty acid synthase (FAS) was shown to regulate inflammation by sustaining neutrophil viability through modulation of membrane phospholipid composition. Neutrophils are the most abundant... Read more

Drug Discovery

view channel
Image: Researchers have attached two drugs—TRAIL and Dox—onto graphene strips. TRAIL is most effective when delivered to the external membrane of a cancer cell, while Dox is most effective when delivered to the nucleus, so the researchers designed the system to deliver the drugs sequentially, with each drug hitting a cancer cell where it will do the most damage (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Anticancer Drug Delivery System Utilizes Graphene Strip Transporters

The ongoing search by cancer researchers for targeted drug delivery systems has generated a novel approach that uses graphene strips to transport simultaneously the anticancer agents TRAIL (tumor necrosis... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Therapeutics

view channel
Image: Cancer cells infected with tumor-targeted oncolytic virus (red). Green indicates alpha-tubulin, a cell skeleton protein. Blue is DNA in the cancer cell nuclei (Photo courtesy of Dr. Rathi Gangeswaran, Bart’s Cancer Institute).

Innovative “Viro-Immunotherapy” Designed to Kill Breast Cancer Cells

A leading scientist has devised a new treatment that employs viruses to kill breast cancer cells. The research could lead to a promising “viro-immunotherapy” for patients with triple-negative breast cancer,... Read more

Business

view channel

Biotech Acquisition Designed to Accelerate the Development and Marketing of Immunosequencing Applications

Adaptive Biotechnologies Corp. (Seattle, WA, USA), a developer of next-generation sequencing (NGS) to profile T-cell and B-cell receptors, has acquired of Sequenta, Inc. (South San Francisco, CA, USA), which is expected to expedite and expand the use of innovative immunosequencing technology for researchers and clinicians... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.